South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting ...
Bizcommunity.com on MSN
New hope for HIV prevention in South Africa with lenacapavir approval
The South African Health Products Regulatory Authority (SAHPRA) has announced the registration of lenacapavir, making South ...
The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting ...
By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...
South Africa's Health Product Regulatory Authority (SAHPRA) has approved the use of the twice-yearly HIV prevention drug, lenacapavir. In a statement released on 27 October, the regulatory body said ...
SAHPRA has registered Lenacapavir, a new six-monthly PrEP injection to prevent HIV-1 in adults and adolescents over 35 kg.
AllAfrica on MSN
South Africa: SA Becomes The First African Country to Register the Twice-a-year Anti-HIV Jab — at Record Speed
South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...
Africanews on MSN
South Africa gives twice-yearly HIV prevention jab the green light
It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.
South Africa’s Health Product Regulatory Authority (SAHPRA) has approved the use of the twice-yearly HIV prevention drug, lenacapavir. In a statement released on 27 October, the regulatory body said ...
Kenya's health ministry, through NASCOP, NSDCC, KRCS, county governments, partners and communities, is committed to ending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback